Humanity & Health Research Centre   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Hong Kong Hong Kong (2009)

Organization Overview

First Clinical Trial
2015
NCT02473211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Humanity and Health GI and Liver Centre | Humanity and Health Research Centre | Humanity & Health Medical Group Limited | Humanity & Health Research Centre | Humanity & Healthy GI and Liver Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Coinfection (Phase 3)

Communicable Diseases (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Infections (Phase 4)

Purpura (Phase 2)

Purpura, Thrombocytopenic (Phase 2)

Purpura, Thrombocytopenic, Idiopathic (Phase 2)

Thrombocytopenia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 24